Curcumin: A novel treatment for skin-related disorders

Journal of Drugs in Dermatology

Volumn 12, Issue 10, 2013, Pages 1131-1137

  Nguyen, Tuyet A ^a   Friedman, Adam J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CALCIPOTRIOL; CORTICOSTEROID; COSMETIC; CURCUMIN; CYTOTOXIC AGENT; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; PHOTOSENSITIZING AGENT; PLACEBO; RETINOID; TURMERIC;

ALLERGY; ALTERNATIVE MEDICINE; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; ARTICLE; ASTHMA; BASAL CELL CARCINOMA; BREAST CANCER; CHRONIC PAIN; COLON CANCER; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG SOLUBILITY; DRUG TARGETING; EXTRACELLULAR MATRIX; FEVER; HUMAN; LICHEN PLANUS; LIVER CANCER; MELANOMA; MOUTH CANCER; NONHUMAN; PATIENT COMPLIANCE; PHOTODYNAMIC THERAPY; PIGMENT DISORDER; POLLUTANT; PROPHYLAXIS; PSORIASIS; RHEUMATOID ARTHRITIS; SCLERODERMA; SKIN CANCER; SKIN DISEASE; SKIN INFECTION; SQUAMOUS CELL CARCINOMA; TINEA; TINEA PEDIS; UNSPECIFIED SIDE EFFECT; WOUND; WOUND CLOSURE; WOUND HEALING;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CURCUMA; CURCUMIN; HUMANS; LICHEN PLANUS; MELANOMA; PSORIASIS; SCLERODERMA, DIFFUSE; SKIN DISEASES; SKIN NEOPLASMS;

EID: 84885460071     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Turmeric: The Genus Curcuma. Boca Raton, Fl: Taylor and Francis Group, LLC; 2007.
2. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1-75.
3. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. Jul-Aug 2001;21(4B):2895-2900.
4. Kaur S, Modi NH, Panda D, Roy N. Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ-A structural insight to unveil antibacterial activity of curcumin. Eur J Med Chem. Vol 45. France: 2010 Elsevier Masson SAS; 2010:4209-4214.
5. Hegge AB, Nielsen TT, Larsen KL, Bruzell E, Tonnesen HH. Impact of curcumin supersaturation in antibacterial photodynamic therapy-effect of cyclodextrin type and amount: studies on curcumin and curcuminoides XLV. J Pharm Sci. Apr 2012;101(4):1524-1537.
6. Haukvik T, Bruzell E, Kristensen S, Tonnesen HH. A screening of curcumin derivatives for antibacterial phototoxic effects studies on curcumin and curcuminoids. XLIII. Pharmazie. Jan 2011;66(1):69-74.
7. Liang G, Yang S, Jiang L, et al. Synthesis and anti-bacterial properties of mono-carbonyl analogues of curcumin. Chem Pharm Bull (Tokyo). Feb 2008;56(2):162-167.
8. Zhang ZJ, Zhao LX, Cao DL, Zhang X, Gao YJ, Xia C. Curcumin Inhibits LPSInduced CCL2 Expression via JNK Pathway in C6 Rat Astrocytoma Cells. Cellular and molecular neurobiology. Aug 2012;32(6):1003-1010.
9. Duke JA, Duke P-AK, DuCellie JL. Duke's Handbook of Medicinal Plants of the Bible. Boca Raton, Fl: Taylor and Francis Group, LLC; 2008.
10. Neelofar K, Shreaz S, Rimple B, Muralidhar S, Nikhat M, Khan LA. Curcumin as a promising anticandidal of clinical interest. Canadian journal of microbiology. Mar 2011;57(3):204-210.
11. Logan-Smith MJ, Lockyer PJ, East JM, Lee AG. Curcumin, a molecule that inhibits the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2+. J Biol Chem. Vol 276. United States2001:46905-46911.
12. Garcia-Gomes AS, Curvelo JA, Soares RM, Ferreira-Pereira A. Curcumin acts synergistically with fluconazole to sensitize a clinical isolate of Candida albicans showing a MDR phenotype. Medical mycology : official publication of the International Society for Human and Animal Mycology. Jan 2012;50(1):26-32.
13. Dovigo LN, Pavarina AC, Carmello JC, Machado AL, Brunetti IL, Bagnato VS. Susceptibility of clinical isolates of Candida to photodynamic effects of curcumin. Lasers Surg Med. Nov 2011;43(9):927-934.
14. Chandran B, Goel A. A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis. Phytotherapy research : PTR. Mar 9 2012.
15. Huang WT, Niu KC, Chang CK, Lin MT, Chang CP. Curcumin inhibits the increase of glutamate, hydroxyl radicals and PGE2 in the hypothalamus and reduces fever during LPS-induced systemic inflammation in rabbits. Eur J Pharmacol. Vol 593. Netherlands2008:105-111.
16. Heng MC, Song MK, Harker J, Heng MK. Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol. Vol 143. England2000:937-949.
17. Tourkina E, Gooz P, Oates JC, Ludwicka-Bradley A, Silver RM, Hoffman S. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol. Vol 31. United States2004:28-35.
18. Gulcubuk A, Altunatmaz K, Sonmez K, et al. Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine. Feb 2006;53(1):49-54.
19. Tian F, Zhang C, Tian W, Jiang Y, Zhang X. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice. Oncol Rep. Jul 2012;28(1):232-240.
20. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. Feb 1 1991;51(3):813-819.
21. Archier E, Devaux S, Castela E, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. May 2012;26 Suppl 3:22-31.
22. Pol A, Bergers M, Schalkwijk J. Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. In vitro cellular & developmental biology. Animal. Jan-Feb 2003;39(1-2):36-42.
23. Sun J, Han J, Zhao Y, Zhu Q, Hu J. Curcumin induces apoptosis in tumor necrosis factor-alpha-treated HaCaT cells. Int Immunopharmacol. Vol 13. Netherlands: 2012 Elsevier B.V; 2012:170-174.
24. Hsu YC, Chen MJ, Yu YM, Ko SY, Chang CC. Suppression of TGF-beta1/ SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch Dermatol Res. Dec 2010;302(10):717-724.
25. Tourkina E, Gooz P, Pannu J, et al. Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J Biol Chem. Vol 280. United States2005:13879-13887.
26. Conboy L, Foley AG, O'Boyle NM, et al. Curcumin-induced degradation of PKC delta is associated with enhanced dentate NCAM PSA expression and spatial learning in adult and aged Wistar rats. Biochem Pharmacol. Vol 77. England2009:1254-1265.
27. Song K, Peng S, Sun Z, Li H, Yang R. Curcumin suppresses TGF-beta signaling by inhibition of TGIF degradation in scleroderma fibroblasts. Biochem Biophys Res Commun. Aug 12 2011;411(4):821-825.
28. Chainani-Wu N, Silverman S, Jr., Reingold A, et al. A randomized, placebocontrolled, double-blind clinical trial of curcuminoids in oral lichen planus. Phytomedicine. Vol 14. Germany2007:437-446.
29. Chainani-Wu N, Madden E, Lozada-Nur F, Silverman S, Jr. High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. J Am Acad Dermatol. Vol 66. United States: Inc. Published by Mosby, Inc; 2012:752-760.
30. Gururaj AE, Belakavadi M, Venkatesh DA, Marme D, Salimath BP. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun. Vol 297. United States2002:934-942.
31. Shan B, Schaaf C, Schmidt A, et al. Curcumin suppresses HIF-1A synthesis and VEGFA release in pituitary adenomas. J Endocrinol2012.
32. Surh YJ, Chun KS. Cancer chemopreventive effects of curcumin. Adv Exp Med Biol. 2007;595:149-172.
33. Park K, Lee JH. Photosensitizer effect of curcumin on UVB-irradiated HaCaT cells through activation of caspase pathways. Oncol Rep. Mar 2007;17(3):537-540.
34. Bush JA, Cheung KJ, Jr., Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res. Vol 271. United States2001:305-314.
35. Park MJ, Kim EH, Park IC, et al. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. International journal of oncology. Aug 2002;21(2):379-383.
36. Ip SW, Wu SY, Yu CC, et al. Induction of apoptotic death by curcumin in human tongue squamous cell carcinoma SCC-4 cells is mediated through endoplasmic reticulum stress and mitochondria-dependent pathways. Cell Biochem Funct. Dec 2011;29(8):641-650.
37. Wang D, Veena MS, Stevenson K, et al. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res. Vol 14. United States2008:6228-6236.
38. Abusnina A, Keravis T, Yougbare I, Bronner C, Lugnier C. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol Nutr Food Res. Nov 2011;55(11):1677-1689.
39. Kakar SS, Roy D. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. Vol 87. Ireland1994:85-89.
40. Limtrakul P, Anuchapreeda S, Lipigorngoson S, Dunn FW. Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin. BMC Cancer. 2001;1:1.
41. Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53- dependent manner. J Biol Chem. Vol 280. United States2005:20059-20068.
42. Joe B, Lokesh BR. Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids. Nov 1997;32(11):1173-1180.
43. Park K, Lee JH. Bcl-XL protein is markedly decreased in UVB-irradiated basal cell carcinoma cell lines through proteasome-mediated degradation. Oncol Rep. Mar 2009;21(3):689-692.
44. Jee SH, Shen SC, Tseng CR, Chiu HC, Kuo ML. Curcumin induces a p53- dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol. Oct 1998;111(4):656-661.
45. Phillips JM, Clark C, Herman-Ferdinandez L, et al. Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo. Otolaryngol Head Neck Surg. Jul 2011;145(1):58-63.
46. Ye F, Zhang GH, Guan BX, Xu XC. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World J Gastroenterol. Jan 14 2012;18(2):126-135.
47. Odot J, Albert P, Carlier A, Tarpin M, Devy J, Madoulet C. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int J Cancer. Sep 1 2004;111(3):381-387.
48. Marin YE, Wall BA, Wang S, et al. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res. Vol 17. England2007:274-283.
49. Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L. Preparation of curcuminloaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 2012;17(5):5972-5987.
50. Moos PJ, Edes K, Mullally JE, Fitzpatrick FA. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis. Vol 25. England2004: 1611-1617.
51. Hata M, Sasaki E, Ota M, et al. Allergic contact dermatitis from curcumin (turmeric). Contact Dermatitis. Feb 1997;36(2):107-108.
52. Swierczynska MK, Krecisz B. [Occupational skin changes in persons working in contact with food spices]. Med Pr. 1998;49(2):187-190.